Skip to main content
Journal cover image

Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.

Publication ,  Journal Article
Iba, T; Levy, JH; Levi, M
Published in: Thromb Haemost
January 2022

Several viral infectious diseases have emerged or re-emerged from wildlife vectors that have generated serious threats to global health. Increased international travel and commerce increase the risk of transmission of viral or other infectious diseases. In addition, recent climate changes accelerate the potential spread of domestic disease. The coronavirus disease 2019 (COVID-19) pandemic is an important example of the worldwide spread, and the current epidemic will unlikely be the last. Viral hemorrhagic fevers, such as dengue and Lassa fevers, may also have the potential to spread worldwide with a significant impact on public health with unpredictable timing. Based on the important lessons learned from COVID-19, it would be prudent to prepare for future pandemics of life-threatening viral diseases. The key concept that connect COVID-19 and viral hemorrhagic fever is the coagulation disorder. This review focuses on the coagulopathy of acute viral infections since hypercoagulability has been a major challenge in COVID-19, but represents a different presentation compared with viral hemorrhagic fever. However, both thrombosis and hemorrhage are understood as the result of thromboinflammation due to viral infections, and the role of anticoagulation is important to consider.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Thromb Haemost

DOI

EISSN

2567-689X

Publication Date

January 2022

Volume

122

Issue

1

Start / End Page

8 / 19

Location

Germany

Related Subject Headings

  • Thrombosis
  • Thromboinflammation
  • SARS-CoV-2
  • Pandemics
  • Models, Biological
  • Immunity, Innate
  • Humans
  • Hemorrhagic Fevers, Viral
  • Global Health
  • Cytokine Release Syndrome
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Iba, T., Levy, J. H., & Levi, M. (2022). Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic. Thromb Haemost, 122(1), 8–19. https://doi.org/10.1055/a-1562-7599
Iba, Toshiaki, Jerrold H. Levy, and Marcel Levi. “Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.Thromb Haemost 122, no. 1 (January 2022): 8–19. https://doi.org/10.1055/a-1562-7599.
Iba T, Levy JH, Levi M. Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic. Thromb Haemost. 2022 Jan;122(1):8–19.
Iba, Toshiaki, et al. “Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.Thromb Haemost, vol. 122, no. 1, Jan. 2022, pp. 8–19. Pubmed, doi:10.1055/a-1562-7599.
Iba T, Levy JH, Levi M. Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic. Thromb Haemost. 2022 Jan;122(1):8–19.
Journal cover image

Published In

Thromb Haemost

DOI

EISSN

2567-689X

Publication Date

January 2022

Volume

122

Issue

1

Start / End Page

8 / 19

Location

Germany

Related Subject Headings

  • Thrombosis
  • Thromboinflammation
  • SARS-CoV-2
  • Pandemics
  • Models, Biological
  • Immunity, Innate
  • Humans
  • Hemorrhagic Fevers, Viral
  • Global Health
  • Cytokine Release Syndrome